Document Detail

Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.
MedLine Citation:
PMID:  8826994     Owner:  NLM     Status:  MEDLINE    
The objective of this study was to describe the association between the epsilon 4 allele of the apolipoprotein E gene (APOE E4) and Alzheimer's disease (AD) and to evaluate APOE E4 genotyping as a test for AD. The study base of this case-control study included about 23,000 persons 60 year of age or greater (a large health maintenance organization); the demographic characteristics of this group are similar to those of the surrounding area. Analysis focused on 234 Caucasian probable AD patients first identified between 1987 and 1993; and 304 cognitively intact controls of similar age, sex, and race who were randomly selected from the same study base. All cases were examined and diagnosed by study physicians using standard protocols. All subjects participate in continuing annual follow-up testing to verify their cognitive status. APOE genotypes were determined from blood samples using standard laboratory methods. Subject characteristics and diagnoses were obtained from interviews, diagnostic examination, or medical record review. Heterozygous E4 individuals had a crude odds ratio of 3.1 (2.1-4.5) for AD compared to those with no E4, while homozygous E4 subjects had an odds ratio of 34.3 (8.0-146.3) for AD. As an indicator of AD, having one E4 allele showed a sensitivity of 0.52 and a specificity of 0.74. Homozygous E4 genotype had a sensitivity of 0.23 and a specificity of 0.99 (when compared to non-E4 genotypes). Cardiovascular disease differed in cases and controls, but did not confound or modify the APOE E4-AI) association. In this study base, the APOE E4 allele was a significant risk factor. However, considering either homozygous or heterozygous E4 genotype as a screen or diagnostic marker for AD would miss many true cases and could misclassify many normals as AD.
W A Kukull; G D Schellenberg; J D Bowen; W C McCormick; C E Yu; L Teri; J D Thompson; E S O'Meara; E B Larson
Related Documents :
22751254 - Adiposity has differing associations with incident coronary heart disease and mortality...
17020404 - Combining information from common type 2 diabetes risk polymorphisms improves disease p...
22532814 - Fertility preservation in women with malignant tumors and gonadotoxic treatments.
20666624 - Itgam arg77his is associated with disease susceptibility, arthritis, and renal symptoms...
25407714 - Community-dwelling older people with an injurious fall are likely to sustain new injuri...
16254254 - Apolipoprotein e genotype in matched men and women with coronary heart disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of clinical epidemiology     Volume:  49     ISSN:  0895-4356     ISO Abbreviation:  J Clin Epidemiol     Publication Date:  1996 Oct 
Date Detail:
Created Date:  1996-10-29     Completed Date:  1996-10-29     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8801383     Medline TA:  J Clin Epidemiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1143-8     Citation Subset:  IM    
Department of Epidemiology, University of Washington, Seattle 98195, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Alzheimer Disease / diagnosis,  genetics*
Apolipoproteins E*
Biological Markers
Case-Control Studies
Odds Ratio
Risk Factors
Grant Support
Reg. No./Substance:
0/Apolipoproteins E; 0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Time-trend of sleep disorder in relation to night work: a study of sequential 1-year prevalences wit...
Next Document:  Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis am...